Press release
Innova Biosciences signs out-licensing deal with StressMarq Biosciences
Cambridge, UK, September 26, 2012 - Innova Biosciences (Cambridge, UK), inventor of the world’s easiest to use bioconjugation kits, is pleased to announce that the company has entered into a licensing agreement with StressMarq Biosciences (British Columbia, Canada).
The non-exclusive license will allow StressMarq to use Innova’s unique Lightning-Link® technology for commercial purposes. Through the commercialisation deal, StressMarq will create a novel collection of antibody conjugate research tools for the scientific community, with the ultimate objective being the advancement of pioneering science and to elucidate the molecular abnormalities behind disease states such as cancer or diabetes.
Dr Andy Lane, Licensing Manager at Innova Biosciences, said, “This agreement underlines the attractiveness of the Lightning-Link® technology to specialist antibody companies, who can take advantage of the simplicity of the method combined with 100% yields to rapidly increase their catalogue portfolios. We look forward to working with StressMarq, who have an excellent reputation in the research antibody sector.”
Commenting on the agreement StressMarq’s President, Dr Ariel Louwrier, said, “The unique aspects of the Lightning-Link® technology coupled with the core expertise of StressMarq Biosciences in the heat shock protein, cellular stress, ion channels and transporter areas will allow us to better serve the needs of our customers, covering a whole new host of applications. The demonstrated and proven Lightning-Link® technology is an excellent counterpart to our antibody portfolio.”
About Innova Biosciences Limited;
Innova Biosciences is a growing, dynamic business based in Cambridge, UK. At the core of Innova's business are the Lightning-Link® and InnovaCoat™ technologies, which simplify the production of antibody-based reagents. The expanding Lightning-Link® and InnovaCoat™ portfolio is sold to research laboratories, pharmaceutical companies, biotechnology companies and diagnostic companies worldwide. For more information, please see www.innovabiosciences.com.
About StressMarq Biosciences;
StressMarq Biosciences Inc. is a company based in Victoria, British Columbia, Canada, and encompasses what is probably the most experienced combined commercial and scientific heat shock and cellular stress community worldwide. StressMarq Biosciences provide a range of monoclonal and polyclonal antisera, for various research areas including cellular stress, cell signaling, ion channels and apoptosis. For more information, please see www.stressmarq.com.
Contact:
Mathew Taylor
Director
Algorythm Solutions Ltd
10 Torkington St
Stamford, Lincolnshire PE9 2UY
+44 (0)773 403 2112
mtaylor@algorythmsolutions.com
http://www.algorythmsolutions.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Innova Biosciences signs out-licensing deal with StressMarq Biosciences here
News-ID: 237670 • Views: …
More Releases from Algorythm Solutions Ltd
Axicon Labels to Launch New Labelling Service at Foodex 2014
Axicon Labels, part of the Axicon Group, will launch a new ‘print your own’ labelling service at Foodex food and drink expo, 24-26 March at the NEC in Birmingham.
Oxford, UK, January 27, 2014 - Axicon Labels, part of the Axicon Group, will launch a new ‘print your own’ labelling service at Foodex food and drink expo, 24-26 March at the NEC in Birmingham. Foodex is the UK trade show for…
Axicon Labels Offer Premium Service for Food Importers
Axicon labels, part of the Axicon Auto ID group, launch a premium service to the food import sector.
Oxford, UK, November 26, 2013 - Axicon labels, part of the Axicon Auto ID group, launch a premium service to the food import sector. Coverall labels are required on many imported products to comply to stringent EU guidelines on nutritional information, additives, Genetically Modified Organisms (GMO'S) as well as allergens and can…
Axicon Auto ID Launch New On-line Barcode Validation System
Axicon Auto ID Ltd, a world leader in barcode verification, announce the launch of a new online barcode validation system.
Oxford, UK, November 05, 2013 - Axicon Auto ID Ltd, (Oxford, UK) a world leader in barcode verification, announce the launch of a new online barcode validation system.
The Checkrite 5 is a stand alone, on-line barcode validation system that can be used in conjunction with a range of different barcode readers.…
Axicon Auto ID Build Online Video Training Resource
Axicon Auto ID Ltd, (Oxford, UK) a world leader in barcode verification, continue to develop their online video training resource.
Oxford, UK, September 12, 2013 - Axicon Auto ID Ltd, (Oxford, UK) a world leader in barcode verification, continue to develop their online video training resource. The company recently added a new video to compliment the launch of their new Industrial Protection Range (IP), the video is a full product demonstration…
More Releases for Biosciences
Batten Disease Treatment Market Overall Study Report 2022-2028 | Seneb BioScienc …
Coherent Market Insights has released a new research study on the "Batten Disease Treatment Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Batten Disease Treatment Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Batten Disease Treatment Market research report…
Antibody Humanization Market to Witness Huge Growth by Key Players: Accurus Bios …
ReportsnReports publishes the report titled Antibody Humanization that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,…
Bruton's Tyrosine Kinase (Btk) Inhibitors Market 2020-2027 | Leading Players: Ab …
Worldwide Market Reports adds "Bruton's Tyrosine Kinase (Btk) Inhibitors Market 2020 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2027" reports to its database.
This report provides in depth study of "Bruton's Tyrosine Kinase (Btk) Inhibitors Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organisation. The Bruton's Tyrosine Kinase (Btk) Inhibitors Market report also provides an in-depth survey of key players in the market which…
Batten Disease Treatment Market Key companies Profile Like Seneb BioSciences,Bio …
Batten disease is a rare, inherent, and fatal autosomal recessive neural disorder that begins in the childhood but may take a few years to show symptoms. Batten disease is one of the approximately 50 diseases that fall under the category of lysosome shortage disorders. The batten disease also referred as Neuronal ceroid Lipofuscinoses (NCLs), which is a class of life-limiting genetic neurogenerative diseases that are caused due to abnormality of…
Batten Disease Treatment Market Trends, Research And Projections For 2018-2026 | …
Batten disease is a rare, inherent, and fatal autosomal recessive neural disorder that begins in the childhood but may take a few years to show symptoms. Batten disease is one of the approximately 50 diseases that fall under the category of lysosome shortage disorders. The batten disease also referred as Neuronal ceroid Lipofuscinoses (NCLs), which is a class of life-limiting genetic neurogenerative diseases that are caused due to abnormality of…
Batten Disease Treatment Market Competitive Analysis are Seneb BioSciences, Inc. …
According to the Centers for Disease Control and Prevention (CDC), Batten disease is observed in 2-4 per 100,000 live births in the United States on an average. The Batten disease although is rare but has high incidence rates in Finland, Sweden, and other parts of the Europe as compared to rest of the world. According to the Batten Disease Support and Research Association, the batten disease has often been encountered…
